A new study reveals that the use of psychedelic-assisted therapy could significantly reduce symptoms of depression and anxiety in patients with treatment-resistant conditions. Researchers found that participants experienced lasting improvements in mood and emotional well-being after receiving controlled doses of psychedelics in a clinical setting. The findings suggest potential for alternative approaches in mental health treatment, particularly for those who have not responded to conventional therapies. Experts emphasize the need for further investigation to understand long-term effects and safety protocols.